No Detail Found!

Proteomic Profile of Lymphoid Leukemia.

Author(s)
Amer Abdulrahman Almaiman Department of Applied Medical Sciences, Community College, Unaizah, Qassim University, Qassim, Saudi Arabia
Abstract
Lymphoid (or lymphocytic/lymphoblastic) leukemia, one of two major types of leukemias (lymphoid and myeloid), is divided into two subtypes, acute lymphoid leukemia (ALL) and chronic lymphocytic leukemia (CLL), depending on the maturation stage and speed of multiplication of the bone marrow lymphocytes. Early diagnosis and treatment can make the difference between life and death. Advancements in the field of proteomics may allow the development of early biomarkers and more effective agents to combat both these types of cancer, and to better understand the underlying mechanisms of the disease. The aim of this review was to elucidate the pathophysiology of lymphocytic leukemia using cancer proteomics techniques from 2007 until 2017. Only relevant original research articles archived in the Science Direct, PubMed and/or the Google Scholar databases within this period were included, which were a total of 30 studies. The role of proteomes in the detection, diagnosis and treatment of ALL and CLL was examined separately. Overall, the findings of this study confirm the viability of proteome analysis in profiling lymphocytic leukemia; and highlight novel leukemia biomarkers and potential therapeutic targets.
Publication Details
Page(s) 133-145
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 2, Year: 2018

Request the full text from PASTIC

References
Jaffe , E.S., 2001.Tumours of haematopoietic and lymphoid tissues: Pathology and genetics,World health organization classification of tumours -
MacIntyreDA, 2010.Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups,Leukemia 24 788 -97
ZenzT., .Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): Dissecting the contribution of 17p deletion, TP53 mutation,, -
VossT., 2001.Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia,Int J Cancer 91 180 -6
TianQ., 2004.Integrated genomic and proteomic analyses of gene expression in mammalian cells,Mol Cell Proteomics 3 960 -9
UnwinRD, 2006.Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells,Blood 107 4687 -94
Xu , Y., 2014.Construction of protein profile classification model and screening of proteomic signature of acute leukemia,Int J Clin Exp Pathol 7 5569 -
UnwinRD, 2005.Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells,Mol Cell Proteomics 4 924 -35
WardE, 2014.,Cancer J Clin 64 83 -103
Dores G.M., 2012.Acute leukemia incidence and patient survival among children and adults in the United States,,Blood 119 34 -43
HerishanuY., 2013.Biology of chronic lymphocytic leukemia in different microenvironments: Clinical and therapeutic implications,Hematol Oncol Clin North Am 27 173 -206
2001.Pathology and genetics of tumours of haematopoietic and lymphoid tissues,Jaffe ES -
SeiterK, 2016.Therapy for relapsed acute lymphoblastic leukemia: Still a role for standard chemotherapy regimens?,Leuk Res 41 1 -2
AccordiB, 2010.Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL,PLoS One 5 e13552 -
Caligaris-CappioF,Hamblin TJ, 1999.B-cell chronic lymphocytic leukemia: A bird of a different feather,J Clin Oncol 17 399 -
DoresGM, 2007.Chronic lymphocytic leukaemia and small lymphocytic lymphoma: Overview of the descriptive epidemiology,Br J Haematol 139 809 -19
LiH, 2017.Chronic lymphocytic leukemia prognostic index: A new integrated scoring system to predict the time to first treatment in Chinese patients with chronic lymphocytic leukemia,Chin Med J 130 135 -
MulliganSP,TamCS, 2012.Chronic lymphocytic leukemia: Diagnosis and clinical staging, in advances in the treatment of B-cell chronic lymphoc,Leuk 6 -15
KanderovaV, 2016.High-resolution antibody array analysis of childhood acute leukemia cells,Mol Cell Proteomics 15 1246 -61
2015.Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and rensensitization by JNK inhibition,Br J Haematol 171 595 -605
PriolaGM, 2015.Cerebrospinal fluid proteomics in children during induction for acute lymphoblastic leukemia: A pilot study,Pediatric Blood and Cancer 62 1190 -4
SligteNE, 2015.Kinase activity profiling reveals active signal transduction pathways in pediatric acute lymphoblastic leukemia: A new approach for target discovery,Proteomics 15 1245 -54
SahaS., 2014.2DGE and DIGE based proteomic study of malignant B-cells in B-cell acute lymphoblastic leukemia,EuPA Open Proteom 3 13 -26
ChoiDB, 2014.Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemia,Leuk Res 38 1252 -9
Wang D., 2013.Differential protein analysis of lymphocytes between children with acute lymphoblastic leukemia and healthy children,Leuk Lymph 54 381 -6
BraoudakiM., 2013.Protein biomarkers distinguish between highand low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner,J Hematol Oncol 6 52 -
FossEJ, 2012.Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets,J Proteom Res 11 5005 -10
JiangN., 2011.Identification of prognostic protein biomarkers in childhood acute lymphoblastic leukemia (ALL),J Proteom 74 843 -57
HollandM., 2011.ICAM1 expressions are associated with CNS disease in a mouse model of pre-B childhood acute lymphoblastic leukemia,Blood 118 638 -49
2009.Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia,Proteom Sci 7 7 -
Gez S. CrossettB,ChristophersonRI, 2007.Differentially expressed cytosolic proteins in human leukemia and lymphoma cell lines correlate with lineages and functions,Proteins Proteom 1774 1173 -83
JohnstonHE, 2017.Integrated cellular and plasma proteomics of contrasting B-cell cancers reveals common, unique and systemic signatures,Mol Cell Proteom 16 386 -406
2016.Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia,Proteomics 16 1193 -203
HuangPY, 2016.Protein profiles distinguish stable and progressive chronic lymphocytic leukemia,Leukem Lymph 57 1033 -43
NesmiyanovPP,TolkachevBE,StryginAV, 2016.ZO-1 expression shows prognostic value in chronic B cell leukemia,Immunobiology 221 6 -11
EagleGL, 2015.Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia,Mol Cell Proteom 14 933 -945
AlsagabySA, 2014.Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia,J Proteom Res 13 5051 -62
2014.Quantitative proteomics to characterize specific histone H2A proteolysis in chronic lymphocytic leukemia and the myeloid THP-1 cell line,Int J Mol Sci 15 9407 -21
KashubaE, 2013.Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen,J Proteom 91 478 -85
Redondo-Muñoz J. Matrix, ., -
O'Hayre M., 2010.Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis,PloS One 5 e11716 -
Rees-UnwinKS, 2010.Ribosome-associated nucleophosmin 1: Increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia,Br J Haematol 148 534 -43
FanAC, 2009.Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens,Nat Med 15 566 -71
SuX, 2009.Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia,Proteom 9 1197 -1206
CateraR, 2008.Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation,Mol Med 14 665 -74
2008.Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators,Leuk Lymph 49 751 -6
ChurchmanML, 2015.Efficacy of retinoids in IKZF1-mutated BCRABL1 acute lymphoblastic leukemia,Cancer Cell 28 343 -56
FossEJ, 2011.Genetic variation shapes protein networks mainly through non-transcriptional mechanisms,PLoS Biol 9 e1001144 -
SugimotoK., 2015.A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines,Cancer Science 106 1534 -43
IssaqHJ,VeenstraTD, 2008.Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE): Advances and perspectives,Biotechniques 44 697 -
AebersoldR,MannM, 2003.Mass spectrometry-based proteomics,Nature 422 198 -207
0

Citations

0

Downloads

142

Views